Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Sold by Perigon Wealth Management LLC

Perigon Wealth Management LLC trimmed its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,472 shares of the pharmacy operator’s stock after selling 515 shares during the period. Perigon Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $359,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Asset Dedication LLC increased its holdings in shares of Walgreens Boots Alliance by 3.5% in the 1st quarter. Asset Dedication LLC now owns 7,199 shares of the pharmacy operator’s stock valued at $337,000 after acquiring an additional 246 shares during the last quarter. Brave Asset Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 4.1% in the 1st quarter. Brave Asset Management Inc. now owns 6,633 shares of the pharmacy operator’s stock valued at $303,000 after acquiring an additional 263 shares during the last quarter. Horrell Capital Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 0.8% in the 2nd quarter. Horrell Capital Management Inc. now owns 32,178 shares of the pharmacy operator’s stock valued at $1,364,000 after acquiring an additional 267 shares during the last quarter. Highland Capital Management LLC increased its holdings in shares of Walgreens Boots Alliance by 0.9% in the 2nd quarter. Highland Capital Management LLC now owns 30,344 shares of the pharmacy operator’s stock valued at $1,286,000 after acquiring an additional 275 shares during the last quarter. Finally, KLCM Advisors Inc. increased its holdings in shares of Walgreens Boots Alliance by 1.1% in the 2nd quarter. KLCM Advisors Inc. now owns 26,269 shares of the pharmacy operator’s stock valued at $1,114,000 after acquiring an additional 280 shares during the last quarter. 57.12% of the stock is currently owned by institutional investors.

A number of brokerages have recently weighed in on WBA. Barclays lowered their price target on Walgreens Boots Alliance from $50.00 to $45.00 and set an “equal weight” rating for the company in a report on Friday, July 10th. ValuEngine downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Wednesday, May 27th. Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $49.00 to $45.00 and set an “equal weight” rating for the company in a research note on Thursday, July 2nd. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “strong sell” rating and set a $42.00 price objective for the company. in a research note on Friday, July 17th. Finally, Royal Bank of Canada lowered their price objective on Walgreens Boots Alliance from $48.00 to $45.00 and set a “sector perform” rating for the company in a research note on Friday, July 10th. Four research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $46.00.

Shares of Walgreens Boots Alliance stock opened at $40.71 on Friday. The company has a quick ratio of 0.33, a current ratio of 0.69 and a debt-to-equity ratio of 0.57. The firm has a market cap of $35.28 billion, a price-to-earnings ratio of 49.65, a price-to-earnings-growth ratio of 1.74 and a beta of 0.55. The business has a fifty day simple moving average of $41.39 and a 200-day simple moving average of $45.26. Walgreens Boots Alliance Inc has a fifty-two week low of $36.65 and a fifty-two week high of $64.50.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, July 9th. The pharmacy operator reported $0.83 EPS for the quarter, missing the consensus estimate of $1.10 by ($0.27). Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. The company had revenue of $34.63 billion for the quarter, compared to analysts’ expectations of $34.32 billion. During the same period in the prior year, the company earned $1.47 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis. Analysts anticipate that Walgreens Boots Alliance Inc will post 4.68 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Wednesday, August 19th will be issued a dividend of $0.4675 per share. This represents a $1.87 annualized dividend and a dividend yield of 4.59%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. The ex-dividend date is Tuesday, August 18th. Walgreens Boots Alliance’s dividend payout ratio is currently 30.55%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Capital gains and your 401(k) or IRA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.